| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |